Healthy Americas Foundation Report Too Many Drugs Tested on Patients Who Are Not the Ones Who Will Take Them

• The author warns readers that observational studies often produce misleading results regarding the effectiveness of long-term drug therapies. • These studies frequently suffer from healthy user bias, where the people taking the drug are already healthier than those who are not.

• NanoViricides, Inc. filed its Annual Report on Form 10-K with the SEC, detailing the progress of its antiviral drug NV-387. • The company is conducting Phase II trials for NV-387 to treat Ebola and Mpox, noting that there is currently no approved drug for Mpox Clade I or Clade II.

• Health authorities from the Americas approved a new regional strategy on health security on September 30, 2026. • The Pan American Health Organization (PAHO) designed the plan to improve how countries prevent, prepare for, and respond to health emergencies.

• Dozens of healthcare innovation leaders gathered for the second Make America Healthy Again Summit to address national health priorities. • The summit focused on reversing the chronic disease epidemic and increasing the amount of control Americans have over their own health.

• Scientists at the Institute of Animal Virology (IAV) in Kerala are developing an early-warning system to forecast dengue trends and anticipate outbreaks. • The project utilizes artificial intelligence to improve medical imaging, clinical decision-making, and the development of drugs and vaccines.

• A study found that nearly 95% of viral TikTok videos promoting Korean skincare and "glass skin" make misleading claims. • Researchers analyzed viral content to determine how often skincare benefits were exaggerated or unsupported.

• The second Make America Healthy Again Summit recently gathered healthcare innovators to discuss reversing the chronic disease epidemic and increasing patient autonomy. • Featured technologies included a GRAIL blood test capable of detecting over 50 types of cancer before symptoms appear and psychedelic medicines for mental health from Compass Pathways and Definium Therapeutics.

• ANI Pharmaceuticals will present data from its uveitis trial and diabetic macular edema analyses via an on-demand poster. • The company plans to share results from the SYNCHRONICITY trial during an encore presentation on Jan. 21, 2027.

• Hospitals in England are experiencing shortages of common medications, including paracetamol, co-codamol, and the blood pressure drug ramipril. • The health department issued serious shortage protocols to ensure patients can still access ramipril despite its limited supply.

• The Trump administration reshaped U.S. biomedical research by implementing funding cuts and delays to National Institutes of Health (NIH) grants. • These delays impacted long-term grants that are typically awarded for multiple years and paid out annually to cover lab work and staff.

• FDA nominee Dr. Heidi Overton testified before the Senate on Thursday regarding her views on vaccines and abortion. • Dr. Overton stated that the MMR vaccine is safe, effective, and "not lethal," contradicting previous claims made by President Trump.